Elite Pharmaceuticals Inc (ELTP)

[virelle]

Lannet, 300 millions market cap, $8.00 on Nasdaq
Pharma, sales and marketing

Elite, 80 millions market cap, $0.08 on OTCCB
Pharma, generic, Sungen partnership 3 billion+

The quickest way for Elite to list on the nasdaq is to merge with Lannet. The quickest way for Lannet to grow is to merge with Elite.

The new company Elite-Lannet Pharma could quote much higher (1 billion market cap +) on the Nasdaq.

When Nasart indicated at the last conference that he would no longer be behind the microphone next time and that he was not excluded from merging with another company active in sales and marketing, the conclusion seems logical.

The parties just need to find a final agreement and a minimum of time to prepare for the merger.